Top compounds associated with response to RAP2C


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.005
mRNA CCT018159 GDSC1000 pan-cancer AAC 0.098 0.005
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.006
mRNA Bortezomib FIMM pan-cancer AAC 0.39 0.006
mRNA lomeguatrib CTRPv2 pan-cancer AAC -0.1 0.006
mRNA BRD-K88742110 CTRPv2 pan-cancer AAC -0.1 0.006
mRNA etomoxir CTRPv2 pan-cancer AAC -0.11 0.006
mRNA Nilotinib GDSC1000 pan-cancer AAC -0.1 0.006
mRNA ABT-888 CTRPv2 pan-cancer AAC -0.1 0.006
mRNA GSK-1904529A GDSC1000 pan-cancer AAC 0.095 0.006
Download CSV